Yun Yang

68Ga-FAPI and 18F-FDG PET/CT Images of a Patient With Rosai-Dorfman Disease With Liver Involvement.

Qianqian Xue, Wei-bing Miao, Zhenying Chen, 2022, Clinical nuclear medicine.

A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer.

Wei-bing Miao, Huipan Liu, Haojun Chen, 2023, European journal of nuclear medicine and molecular imaging.

A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study.

Jieling Zheng, Wei-bing Miao, Yun Yang, 2024, European journal of nuclear medicine and molecular imaging.

A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers

Zhide Guo, Xiaoyu Chen, J. Zang, 2023, Clinical nuclear medicine.

Diagnostic Performance of [18F]AlF-Thretide PET/CT in Patients with Newly Diagnosed Prostate Cancer Using Histopathology as Reference Standard

Shaoming Chen, Wei-bing Miao, Yun Yang, 2024, The Journal of Nuclear Medicine.